1-6 of 6
Authors: Hon Wai Koon
Journal Article
METABOLOMICS ANALYSIS IDENTIFIED AN ORALLY ACTIVE METABOLITE FOR TREATING CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S47–S48, https://doi.org/10.1093/ibd/izac247.090
Published: 26 January 2023
Journal Article
A NOVEL ORALLY ACTIVE METABOLITE REVERSES CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S61–S62, https://doi.org/10.1093/ibd/izac015.098
Published: 22 January 2022
Journal Article
P-234 YI High Intestinal Cathelicidin Level Predicts Good Prognosis of Ulcerative Colitis Patients Get access
Inflammatory Bowel Diseases, Volume 18, Issue suppl_1, 1 December 2012, Page S105, https://doi.org/10.1097/00054725-201212001-00267
Published: 01 December 2012
Journal Article
P-246 Autophagy is Involved in Optimal Expression of TL1A (TNFSF15) by Microbes in Primary Human Monocytes Get access
Inflammatory Bowel Diseases, Volume 18, Issue suppl_1, 1 December 2012, Page S109, https://doi.org/10.1097/00054725-201212001-00279
Published: 01 December 2012
Journal Article
P-233 YI Anti-fibrogenic Roles of Cathelicidin in Chronic Colitis Associated Colonic Fibrosis Get access
Inflammatory Bowel Diseases, Volume 18, Issue suppl_1, 1 December 2012, Page S105, https://doi.org/10.1097/00054725-201212001-00266
Published: 01 December 2012
Journal Article
Anti-fibrogenic roles of cathelicidin in chronic colitis associated colonic fibrosis: P-231.
Get access
Inflammatory Bowel Diseases, Volume 17, Issue Suppl_2, 1 December 2011, Pages S80–S81, https://doi.org/10.1097/00054725-201112002-00265
Published: 01 December 2011
